Papaevangelou V, Alexopoulou Z, Hadjichristodoulou C, Kourlamba G, Katsioulis A, Theodoridou K, Spoulou V, Theodoridou M
a Third Department of Pediatrics , National and Kapodistrian University of Athens School of Medicine , Athens , Greece.
b First Department of Pediatrics , National and Kapodistrian University of Athens School of Medicine , Athens , Greece.
Hum Vaccin Immunother. 2016 Jul 2;12(7):1852-6. doi: 10.1080/21645515.2016.1151589. Epub 2016 May 4.
Hepatitis A vaccine was introduced in the Greek National Immunization Program in 2008. To estimate possible impact of the universal vaccination implementation, time trends of hospitalizations for hepatitis A at the Infectious Diseases Unit of a Tertiary Pediatric Hospital in Athens during 1999-2013 were analyzed. Hepatitis A hospitalizations were recorded from the discharge database and were expressed as frequencies and rate of annual departmental hospitalizations. Time series analysis (ARIMA) was used to explore trends and the impact of the vaccination. Moreover, changes in patient age, population group distribution and the duration of hospitalization were also examined. Hepatitis A hospitalizations rate significantly decreased between pre-vaccination (1999-2008) and post-vaccination (2009-2013) era from 50.5 to 20.8/1000 hospitalizations (p = 0.005). A 3-year periodicity and a trend of reduction on hepatitis A hospitalizations rates across years were noted. Roma children had significant higher rates of hepatitis A hospitalization, followed by immigrant children. Importantly, possibly due to preceding vaccine availability with considerable uptake in private market and unvaccinated group/pockets of children (Roma), overall vaccination effect was less apparent when compared to data from other countries that implemented universal vaccination. No significant change in patient age, population group distribution, or duration of hospitalization was observed. High risk groups such as Roma children should be targeted for vaccination to reduce future outbreaks.
甲型肝炎疫苗于2008年被纳入希腊国家免疫规划。为评估普遍接种疫苗可能产生的影响,对1999年至2013年期间雅典一家三级儿科医院传染病科甲型肝炎住院病例的时间趋势进行了分析。从出院数据库中记录甲型肝炎住院病例,并以年度科室住院病例的频率和比率表示。采用时间序列分析(ARIMA)来探讨趋势和疫苗接种的影响。此外,还检查了患者年龄、人群分布和住院时间的变化。在疫苗接种前(1999 - 2008年)和接种后(2009 - 2013年)期间,甲型肝炎住院率从50.5/1000例住院显著下降至20.8/1000例住院(p = 0.005)。观察到甲型肝炎住院率存在3年的周期性以及逐年下降的趋势。罗姆儿童的甲型肝炎住院率显著更高,其次是移民儿童。重要的是,可能由于之前疫苗在私人市场有相当的接种量以及未接种疫苗的儿童群体(罗姆人),与其他实施普遍接种疫苗的国家的数据相比,总体疫苗接种效果不太明显。未观察到患者年龄、人群分布或住院时间有显著变化。应将罗姆儿童等高风险群体作为疫苗接种目标,以减少未来的疫情爆发。